Skip navigation
Navigation skipped

News Releases

Media AdvisoryBMO Capital Markets to Host Annual “Focus on Healthcare” Investor Conference

BMO Capital Markets, the investment and corporate banking arm of BMO Financial Group (NYSE, TSX: BMO), will host its annual Focus on Healthcare Conference on December 4th and 5th at the Millennium Broadway Hotel in New York City.

The event brings together a number of senior management from leading and emerging companies for an in-depth review of the healthcare industry's current challenges and future opportunities:

Hosted by members of the BMO Capital Markets Healthcare Equity Research Team including Erik Chiprich, Robert Hazlett, Dave Shove, Joanne Wuensch and Jason Zhang, this two-day event features a unique mix of presentations by public and private companies focused on the following sectors:

  • Biotechnology
  • Healthcare Facilities
  • Medical Technology & Devices
  • Pharmaceuticals & Specialty Pharmaceuticals

BMO Capital Markets is also proud to welcome keynote speaker, former U.S. Senate Majority Leader Bill Frist, M.D.  As a leading American physician, businessman and former U.S. Senator, Dr. Frist has emerged as one of the leading voices on health issues in America today.

The conference will be webcast live and archived on the BMO Capital Markets website: http://www.bmocm.com/conferences/2007healthcare.

An up-to-the-minute agenda* with presentation times for the entire conference is also available on the website.

Media interested in attending the event and/or scheduling an interview are asked to call (416) 867-3996.

A total of 89 companies are scheduled to participate. They include:

�terna Zentaris, Inc. (AEZS)

Akela Pharma Inc. (AKL.TO)

Allos Therapeutics (ALTH)

Alphatec Spine, Inc. (ATEC)

Amedisys, Inc. (AMED)

American CareSource Holdings (XSI)

Antares Pharma, Inc. (AIS)

Arqule, Inc. (ARQL)

ArthroCare Corporation (ARTC)

Assisted Living Concepts (ALC)

Atricure (ATRC)

Bio-Imaging Technologies, Inc. (BITI)

Bionovo (BNVI.OB)

BioSphere Medical (BSMD)

Boston Scientific Corp. (BSX)

Capital Senior Living (CSU)

Cardiva Medical

Celgene Corp. (CELG)

CollaGenex Pharmaceuticals, Inc. (CGPI)

Continucare Corp. (CNU)

Cortex Pharmaceuticals, Inc. (COR)

CryoCath Technologies (CYT)

Elite Pharmaceuticals, Inc. (ELI)

Enzon Pharmaceuticals (ENZN)

EpiCept Corp. (EPCT)

ESTECH

Extendicare Real Estate Investment Trust (EXE.UN)

eyeonics, inc.

Greatbatch, inc. (GB)

Idera Pharmaceuticals (IDP)

Immtech Pharmaceuticlas, Inc. (IMM)

Immunogen, Inc. (IMGN)

Innovative Spinal Technologies, Inc.

Integra Lifesciences Corp (IART)

King Pharmaceuticals, Inc. (KG)

LCA-Vision, Inc. (LCAV)

MacroGenics

MedCath Corp. (MDTH)

Medical Facilities Corp. (DR.UN)

Medicalis

MethylGene, Inc. (MYG.TO)

MGI Pharma (MOGN)

Millennium Pharmaceuticals (MLNM)

MIV Therapeutics (MIVT)

MX USA

Nabi Biopharmaceuticals, Inc. (NABI)

Napo Pharmaceuticals, Inc.

Nastech Pharmaceutical Company, Inc. (NSTK)

Nektar Therapeutics (NKTR)

NorthStar Healthcare Inc. (NHC)

Novadaq Technologies (NDQ)

NovaMed, Inc. (NOVA)

Novavax, Inc. (NVAX)

Numoda Corp.

Oscient Pharmaceuticals (OSCI)

Paratek Pharmaceuticals

Penwest (PPCO)

Pharmacopeia (PCOP)

Possis Medical, Inc. (POSS)

Pozen Inc. (POZN)

Progenics Pharmaceuticals, Inc. (PGNX)

Protein Sciences Corp.

Questcor Pharmaceuticals, Inc. (QSC)

Regeneron Pharmaceuticals, Inc. (REGN)

ReNeuron Group plc (RENE.L)

Repligen Corporation (RGEN)

ResMed (RMD)

Respironics, Inc. (RESP)

Response Biomedical Corporation (RBM)

Rib-X Pharmaceuticals

Salix Pharmaceuticals (SLXP)

Sangamo BioSciences, Inc. (SGMO)

SCYNEXIS

SenoRx (SENO)

Sepracor Inc. (SEPR)

STAAR Surgical (STAA)

SuperGen (SUPG)

The Cooper Companies Inc. (COO)

The Parker Group

The Schumacher Group

Theratechnologies, Inc. (TH.TO)

TissueLink

TLCVision Corp. (TLCV)

Topigen Pharmaceuticals

U.S. Physical Therapy, Inc. (USPH)

Universal Health Services, Inc. (UHS)

Vitae Pharmaceuticals, Inc.

Xtent, Inc. (XTNT)

Zimmer Holdings Inc. (ZMH)

* Agenda and participant list subject to change.

About BMO Capital Markets

BMO Capital Markets is a leading full-service North American financial services provider, with over 2,000 employees operating in 14 North American offices and 26 worldwide, offering corporate, institutional and government clients access to a complete range of investment and corporate banking products and services.  BMO Capital Markets is a member of BMO Financial Group (NYSE, TSX: BMO), one of the largest diversified financial services providers in North America with more than CAN$366.5 billion in total assets and more than 35,000 employees as at October 31, 2007. For more information, visit www.bmocm.com.

For further information: